$48.18
-1.31-2.65%
At Close: -
$48.25
0.070.15%
After Hours: Sep 20, 5:20 PM EDT
15 minutes delayed
CRISPR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-1.49 | $-1.52 | 1.97 % |
Mar 2024 | 2024-05-08 | $-1.43 | $-1.42 | -0.70 % |
Dec 2023 | 2024-02-21 | $1.10 | $-0.07 | 1671.4 % |
Sep 2023 | 2023-11-06 | $-1.41 | $-1.96 | 28.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $517.00K | $3.54M | -85.4 % |
Mar 2024 | 2024-05-08 | $504.00K | $28.11M | -98.2 % |
Dec 2023 | 2024-02-21 | $201.21M | $131.63M | 52.9 % |
Sep 2023 | 2023-11-06 | $0 | $8.43M | -100.0 % |
CRISPR Therapeutics (CRSP) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-1.49, which beat the estimate of $-1.52.
The Actual Revenue was $517K, which missed the estimate of $3.5M.
Browse earnings estimates, EPS, and revenue on all stocks.